Cargando…

Anti-schistosomal immunity to core xylose/fucose in N-glycans

Schistosomiasis is a globally prevalent, debilitating disease that is poorly controlled by chemotherapy and for which no vaccine exists. While partial resistance in people may develop over time with repeated infections and treatments, some animals, including the brown rat (Rattus norvegicus), are on...

Descripción completa

Detalles Bibliográficos
Autores principales: Prasanphanich, Nina Salinger, Leon, Kristoffer, Secor, W. Evan, Shoemaker, Charles B., Heimburg-Molinaro, Jamie, Cummings, Richard D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110957/
https://www.ncbi.nlm.nih.gov/pubmed/37081851
http://dx.doi.org/10.3389/fmolb.2023.1142620
_version_ 1785027357701046272
author Prasanphanich, Nina Salinger
Leon, Kristoffer
Secor, W. Evan
Shoemaker, Charles B.
Heimburg-Molinaro, Jamie
Cummings, Richard D.
author_facet Prasanphanich, Nina Salinger
Leon, Kristoffer
Secor, W. Evan
Shoemaker, Charles B.
Heimburg-Molinaro, Jamie
Cummings, Richard D.
author_sort Prasanphanich, Nina Salinger
collection PubMed
description Schistosomiasis is a globally prevalent, debilitating disease that is poorly controlled by chemotherapy and for which no vaccine exists. While partial resistance in people may develop over time with repeated infections and treatments, some animals, including the brown rat (Rattus norvegicus), are only semi-permissive and have natural protection. To understand the basis of this protection, we explored the nature of the immune response in the brown rat to infection by Schistosoma mansoni. Infection leads to production of IgG to parasite glycoproteins with complex-type N-glycans that contain a non-mammalian-type modification by core α2-Xylose and core α3-Fucose (core Xyl/Fuc). These epitopes are expressed on the surfaces of schistosomula and adult worms. Importantly, IgG to these epitopes can kill schistosomula by a complement-dependent process in vitro. Additionally, sera from both infected rhesus monkey and infected brown rat were capable of killing schistosomula in a manner inhibited by glycopeptides containing core Xyl/Fuc. These results demonstrate that protective antibodies to schistosome infections in brown rats and rhesus monkeys include IgG responses to the core Xyl/Fuc epitopes in surface-expressed N-glycans, and raise the potential of novel glyco-based vaccines that might be developed to combat this disease.
format Online
Article
Text
id pubmed-10110957
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-101109572023-04-19 Anti-schistosomal immunity to core xylose/fucose in N-glycans Prasanphanich, Nina Salinger Leon, Kristoffer Secor, W. Evan Shoemaker, Charles B. Heimburg-Molinaro, Jamie Cummings, Richard D. Front Mol Biosci Molecular Biosciences Schistosomiasis is a globally prevalent, debilitating disease that is poorly controlled by chemotherapy and for which no vaccine exists. While partial resistance in people may develop over time with repeated infections and treatments, some animals, including the brown rat (Rattus norvegicus), are only semi-permissive and have natural protection. To understand the basis of this protection, we explored the nature of the immune response in the brown rat to infection by Schistosoma mansoni. Infection leads to production of IgG to parasite glycoproteins with complex-type N-glycans that contain a non-mammalian-type modification by core α2-Xylose and core α3-Fucose (core Xyl/Fuc). These epitopes are expressed on the surfaces of schistosomula and adult worms. Importantly, IgG to these epitopes can kill schistosomula by a complement-dependent process in vitro. Additionally, sera from both infected rhesus monkey and infected brown rat were capable of killing schistosomula in a manner inhibited by glycopeptides containing core Xyl/Fuc. These results demonstrate that protective antibodies to schistosome infections in brown rats and rhesus monkeys include IgG responses to the core Xyl/Fuc epitopes in surface-expressed N-glycans, and raise the potential of novel glyco-based vaccines that might be developed to combat this disease. Frontiers Media S.A. 2023-04-04 /pmc/articles/PMC10110957/ /pubmed/37081851 http://dx.doi.org/10.3389/fmolb.2023.1142620 Text en Copyright © 2023 Prasanphanich, Leon, Secor, Shoemaker, Heimburg-Molinaro and Cummings. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Molecular Biosciences
Prasanphanich, Nina Salinger
Leon, Kristoffer
Secor, W. Evan
Shoemaker, Charles B.
Heimburg-Molinaro, Jamie
Cummings, Richard D.
Anti-schistosomal immunity to core xylose/fucose in N-glycans
title Anti-schistosomal immunity to core xylose/fucose in N-glycans
title_full Anti-schistosomal immunity to core xylose/fucose in N-glycans
title_fullStr Anti-schistosomal immunity to core xylose/fucose in N-glycans
title_full_unstemmed Anti-schistosomal immunity to core xylose/fucose in N-glycans
title_short Anti-schistosomal immunity to core xylose/fucose in N-glycans
title_sort anti-schistosomal immunity to core xylose/fucose in n-glycans
topic Molecular Biosciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110957/
https://www.ncbi.nlm.nih.gov/pubmed/37081851
http://dx.doi.org/10.3389/fmolb.2023.1142620
work_keys_str_mv AT prasanphanichninasalinger antischistosomalimmunitytocorexylosefucoseinnglycans
AT leonkristoffer antischistosomalimmunitytocorexylosefucoseinnglycans
AT secorwevan antischistosomalimmunitytocorexylosefucoseinnglycans
AT shoemakercharlesb antischistosomalimmunitytocorexylosefucoseinnglycans
AT heimburgmolinarojamie antischistosomalimmunitytocorexylosefucoseinnglycans
AT cummingsrichardd antischistosomalimmunitytocorexylosefucoseinnglycans